1	“ Creating a Competitive Advantage for Life Science Companies in South Carolina”
2	Charter Statewide program to (1) develop emerging life science companies and support (2) recruitment of biotech companies to South Carolina.
3
4	SC Bio Vision Develop incubator system Virtual biotech company structure Support creation of required infrastructure Expand life science research Foster creation of 20,000 new jobs
5	Retaining the Best and Brightest
6	Biotechnology Update
7	What is Biotechnology Technology based on life sciences 130 drugs and vaccines Hundreds medical diagnostic kits Environmental products Agricultural and food products New chemicals, enzymes Textiles, pulp & paper
8	Industry Statistics Doubled total product sales since 1996 Doubled total revenues since 1996 Patents/Yr. 1996 = 4,600 2000 = 14,000 New drug approvals 20 – 32/year Average per employee salary $50,000 NC
9	Product Examples Human Growth Hormone TPA Detergent enzymes Transgenic pigs Transgenic tobacco Bio-pesticides Peptide production Veterinary products Animal feed supplements EPO Implant Devices Hemoglobin Sepsis T-Cell Lymphoma Textiles Biochemicals Vaccines HIV Diagnostics
10	Market Capitalization Billion Dollars
11	Biotech Company Revenues Billion Dollars
12	Biotech Private and Public Companies
13	Biotechnology Employment
14	Biotech Industry Financing
15	5-7 Year Industry Trends Commercialization / Manufacturing Greenfield opportunities in the SE Diversification outside of pharmaceuticals Agricultural Chemical/Environmental International Programs (Europe & Asia) Good IPO market Equity market returning to biotechnology Pharmaceuticals/biotechnology
16	Implications for South Carolina
17	Life Science in South Carolina Changing economy post NAFTA and development of international markets Impact of GATT 2005, European Union Mexico, China, CBI, Puerto Rico 936 NAFTA and South Carolina Importance of research/technology based economies
18	Legislative Activities Life Science Act Venture Capital Act
19	Why All of South Carolina Can Participate Transgenic tobacco in Florence Transgenic trees in Charleston Natural protein textile research Bioterrorism vaccines in Charleston Industrial enzymes in Kingstree Clinical trials across South Carolina Biopharmaceutical companies in Sumter Combinatory chemistry Rock Hill Contract manufacturing in Charleston
20	The Monitor Study Chemicals (Biotechnology/Life Sciences) Automotive Textile Tourism
21
22	Why SC for Recruiting and Developing Biotechnology Natural resources for manufacturing. History of international companies. Mobile technology. Tax environment (Additional pending legislation). Unique resources and qualifications each research institution.
23	Enhancing Competitive Position Endowed chairs program. Research collaborations SC research institutions. Commercialization (66% R&D companies). Recruitment (34% Manufacturing companies). Biotechnology image.
24	Implications for The University of South Carolina
25	USC Resources Combinatory Chemistry & Life Sciences Combinatory Chemistry/protein chemistry PEG Genisys Public Health Services USC Medical School Oncology Research Pending Research Park
26	Life Science Opportunities Savannah River Plant/Nuclear Medicine Isotopes linked to unique receptors Diagnostics Expand Transgenic Plant Research Increase Medical Research VA related medical research CNS, vaccines, trauma/battle related Expand USC Clinical Trial Program
27	Path Forward for USC Expand endowed chairs in life sciences. Establish new life science companies. Develop lab incubator. Create image of life science research center. Increase Palmetto Biotechnology Alliance involvement.
28
29	South Carolina Biotechnology Research Institutions
30	Is the Juice Worth the Squeeze Field of operation review (patents) Ability to finance Competitor review Manufacturing model Confidential review
31	SC Bio Karl Kelly: CEO Christine Schwartz: Research Manager Scott Davis: Manager Development Services Ashley Hannah: Manager Communications and Marketing Services Rick Moseley: Facility Engineer/Safety Officer USC, Lander, Citadel: (5) Research Assistants
32	SC Bio Governing Board USC Clemson MUSC Greenwood Genetic Center SCRA SC Dept of Commerce Steven L. Jones Greenwood Economic Alliance GMI
33	Technical and Business Consulting Services Company formation/structure Executive recruitment Financing Product development and clinical trials Manufacturing concept development Marketing and sales agreements
34	Industry Advisory Board Genentech Amgen Merck Roche Carolina DSM Biologics Savient Pharmaceuticals MetaMorphix Diversa Aradigm
35	What Makes SC BIO Unique? Process/Product Development Speed to market Venture recognition of product development “SC can get product in market faster than all other states.”
36	Research Assistant Projects General Research Science review Literature search Competitor information Patent search PBA support SC Bio PR program Recruitment support Special Projects Patent evaluation Mfg model Financing plan Marketing strategy Executive summary Business plan Presentations
37	SC BIO Target Companies Transgenic Plants Biomaterial Textiles Protein Chemistry Pegulation Genetic Diagnostics Oncology Animal Research Models Peptide Drug Delivery BAC Library Development Services
38	Why South Carolina Can Compete History in recruitment Ability to attract funding Research capabilities Business environment Leadership commitment Livability Water Effective electrical costs Favorable permit environment Existing companies
39	Commitment to South Carolina “This program creates new companies and jobs in South Carolina. These new companies will carry the Palmetto State into direct competition with the centers of innovation and development around the world while quietly raising the standard of living at home.”
40